Compare · ELV vs LMRI
ELV vs LMRI
Side-by-side comparison of Elevance Health Inc. (ELV) and Lumexa Imaging Holdings Inc. (LMRI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and LMRI operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.24B, about 110.5x LMRI ($816.7M).
- Over the past year, ELV is up 7.5% and LMRI is down 56.3% - ELV leads by 63.9 points.
- Both names hit the wire about 3 times in the past 4 weeks.
- ELV has more recent analyst coverage (23 ratings vs 9 for LMRI).
PerformanceELV+16.29%LMRI-56.35%
2025-12-11+0.00%2026-06-08
- Company
- Elevance Health Inc.
- Lumexa Imaging Holdings Inc.
- Price
- $418.62+0.71%
- $8.08-5.05%
- Market cap
- $90.24B
- $816.7M
- 1M return
- +12.38%
- -20.94%
- 1Y return
- +7.53%
- -56.35%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 3
- 3
- Recent ratings
- 23
- 9
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)
Latest LMRI
- Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
- Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)
- Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)
- SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure
- Lumexa Imaging Announces First Quarter 2026 Results
- Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
- SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.
- SEC Form DEF 14A filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date